Search This Blog:    HIV   MPOX

DeutschEspañolFrançaisItaliano

 


Efficacy of HIV Vaccine Currently Underway

Efficacy of HIV Vaccine Currently Underway
The HVTN 702 study aims to enroll 5400 HIV-uninfected, sexually active men and women aged 18 to 35 years. The vaccine regimen consists of 2 experimental vaccines: a canarypox vector-based vaccine called ALVAC-HIV (Sanofi Pasteur) and a 2-component gp120 protein subunit vaccine (GlaxoSmithKline). 

Top stories of the last 30 days